DEANNA JOY MYNATT: Open Payments
NPI 1063050151 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 45 payments from 12 companies in 2025. Trend: 2023 $490 · 2024 $845 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 14 | $257 |
| Axsome Therapeutics, Inc. | 5 | $154 |
| Neurocrine BioSciences, Inc. | 6 | $133 |
| Lundbeck LLC | 5 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Alkermes, Inc. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $25 |
Products named: REXULTI, Auvelity, INGREZZA, ABILIFY MAINTENA, CAPLYTA, ARISTADA, AUSTEDO XR, COBENFY.
Industry payments across NM — which companies pay providers there.
